Liu Z - Search Results

1

Discovery of anticancer peptides from natural and generated sequences using deep learning.

Yue J, Li T, Xu J, Chen Z, Li Y, Liang S, Liu Z, Wang Y. Yue J, et al. Among authors: liu z. Int J Biol Macromol. 2024 Dec 18;290:138880. doi: 10.1016/j.ijbiomac.2024.138880. Online ahead of print. Int J Biol Macromol. 2024. PMID: 39706427

2

Targeting the PDK/PDH axis to reverse metabolic abnormalities by structure-based virtual screening with in vitro and in vivo experiments.

Yue J, Xu J, Yin Y, Shu Y, Li Y, Li T, Zou Z, Wang Z, Li F, Zhang M, Liang S, He X, Liu Z, Wang Y. Yue J, et al. Among authors: liu z. Int J Biol Macromol. 2024 Mar;262(Pt 1):129970. doi: 10.1016/j.ijbiomac.2024.129970. Epub 2024 Feb 6. Int J Biol Macromol. 2024. PMID: 38325689

3

Discovery of potential antidiabetic peptides using deep learning.

Yue J, Xu J, Li T, Li Y, Chen Z, Liang S, Liu Z, Wang Y. Yue J, et al. Among authors: liu z. Comput Biol Med. 2024 Sep;180:109013. doi: 10.1016/j.compbiomed.2024.109013. Epub 2024 Aug 12. Comput Biol Med. 2024. PMID: 39137670

4

Discovery of Mcl-1 inhibitors through virtual screening, molecular dynamics simulations and in vitro experiments.

Yue J, Li Y, Li F, Zhang P, Li Y, Xu J, Zhang Q, Zhang C, He X, Wang Y, Liu Z. Yue J, et al. Among authors: liu z. Comput Biol Med. 2023 Jan;152:106350. doi: 10.1016/j.compbiomed.2022.106350. Epub 2022 Nov 26. Comput Biol Med. 2023. PMID: 36493735

5

Molecular action mechanisms of two novel and selective calcium release-activated calcium channel antagonists.

Kong X, Wang F, Chen Y, Liang X, Yin Y, Liu H, Luo G, Li Y, Liang S, Wang Y, Liu Z, Tang C. Kong X, et al. Among authors: liu z, liu h. Int J Biol Macromol. 2023 Dec 31;253(Pt 3):126937. doi: 10.1016/j.ijbiomac.2023.126937. Epub 2023 Sep 16. Int J Biol Macromol. 2023. PMID: 37722647

6

ToxMPNN: A deep learning model for small molecule toxicity prediction.

Zhou Y, Ning C, Tan Y, Li Y, Wang J, Shu Y, Liang S, Liu Z, Wang Y. Zhou Y, et al. Among authors: liu z. J Appl Toxicol. 2024 Jul;44(7):953-964. doi: 10.1002/jat.4591. Epub 2024 Feb 26. J Appl Toxicol. 2024. PMID: 38409892

7

Disintegrin Accutin inhibits A549 cell migration though suppression of EMT and FAK/AKT signaling pathway.

Wu K, Jian S, Han Z, Ding C, Li Y, Wen Y, Nie Y, Zhu J, Li T, Zhang P, Zeng Y, Liu Z. Wu K, et al. Among authors: liu z. Int J Biol Macromol. 2024 Aug;275(Pt 2):133593. doi: 10.1016/j.ijbiomac.2024.133593. Epub 2024 Jul 4. Int J Biol Macromol. 2024. PMID: 38971284

8

Development of human lactate dehydrogenase a inhibitors: high-throughput screening, molecular dynamics simulation and enzyme activity assay.

Shu Y, Yue J, Li Y, Yin Y, Wang J, Li T, He X, Liang S, Zhang G, Liu Z, Wang Y. Shu Y, et al. Among authors: liu z. J Comput Aided Mol Des. 2024 Aug 10;38(1):28. doi: 10.1007/s10822-024-00568-y. J Comput Aided Mol Des. 2024. PMID: 39123063

9

Discovery of the Inhibitor Targeting the SLC7A11/xCT Axis through In Silico and In Vitro Experiments.

Yue J, Yin Y, Feng X, Xu J, Li Y, Li T, Liang S, He X, Liu Z, Wang Y. Yue J, et al. Among authors: liu z. Int J Mol Sci. 2024 Jul 29;25(15):8284. doi: 10.3390/ijms25158284. Int J Mol Sci. 2024. PMID: 39125853 Free article.

10

Glucose-Lipopeptide Conjugates Reveal the Role of Glucose Modification Position in Complexation and the Potential of Malignant Melanoma Therapy.

Zhao X, Zhang P, Li Y, Wu S, Li F, Wang Y, Liang S, He X, Zeng Y, Liu Z. Zhao X, et al. Among authors: liu z. J Med Chem. 2021 Aug 12;64(15):11483-11495. doi: 10.1021/acs.jmedchem.1c00805. Epub 2021 Jul 20. J Med Chem. 2021. PMID: 34282902

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90,527 results

Search Page

Filters